Finance

Lists
Why is 603896 down 2,03%?
Dive Deeper
603896:SHA
Zhejiang Shouxiangu Pharmaceuticl Co Ltd
CN¥14,49
-2,03%
(-0,30) 1D
14 Okt., 14:43:22 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603896...
Open
CN¥14,70
High
CN¥14,78
Low
CN¥14,46
Mkt. cap
2,96 mjd
Avg. vol.
1,70 m
Volume
930,00 k
52-wk high
CN¥22,97
52-wk low
CN¥12,62
EPS
-CN¥0,04
Shares outstanding
139,80 m
No. of employees
1 k
Open
CN¥14,70
High
CN¥14,78
Low
CN¥14,46
Mkt. cap
2,96 mjd
Avg. vol.
1,70 m
Volume
930,00 k
52-wk high
CN¥22,97
52-wk low
CN¥12,62
EPS
-CN¥0,04
Shares outstanding
139,80 m
No. of employees
1 k
News stories
From web sources and news partners
About Zhejiang Shouxiangu Pharmaceuticl Co Ltd
CEO-
Employees1,12 k
Founded1909
Headquarters-
SectorPersonal care products
Websitesxg1909.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
130,45 m
210,04 m
161,03 m
115,01 m
Cost of goods sold
32,54 m
46,50 m
37,09 m
26,98 m
Cost of revenue
32,54 m
46,50 m
37,09 m
26,98 m
Research and development expenses
12,33 m
9,54 m
11,98 m
6,05 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
76,50 m
108,28 m
78,95 m
76,52 m
Operating expense
88,72 m
122,14 m
93,76 m
84,32 m
Total operating expenses
121,26 m
168,64 m
130,85 m
111,30 m
Operating income
9,19 m
41,40 m
30,18 m
3,71 m
Other non operating income
55,07 k
-368,29 k
-80,49 k
-413,64 k
EBT including unusual items
10,72 m
25,72 m
30,24 m
6,72 m
EBT excluding unusual items
6,07 m
37,37 m
26,20 m
1,63 m
Income tax expense
-68,62 k
83,95 m
1,32 m
-1,04 m
Effective tax rate
-0,64%
326,35%
4,36%
-15,44%
Other operating expenses
-907,72 k
4,14 m
2,62 m
2,74 m
Net income
10,78 m
-58,17 m
28,93 m
7,94 m
Net profit margin
8,27%
-27,69%
17,97%
6,90%
Earnings per share
-
-
-
-
Interest and investment income
4,07 m
3,66 m
3,32 m
6,01 m
Interest expense
-7,26 m
-7,32 m
-7,22 m
-7,67 m
Net interest expenses
-3,18 m
-3,66 m
-3,90 m
-1,67 m
Depreciation and amortization charges
-
-
-
-
EBITDA
25,31 m
60,05 m
48,83 m
23,06 m
Gain or loss from assets sale
-75,56 k
-410,54 k
-
-270,40 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme